Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Dominika Zrastakova, 23, from Bath, Somerset, started developing mild acne on her face aged 16, but she assumed it would 'go away eventually'. But it left her in agony and unable to sleep.

In a previous column, I discussed some common medications that can cause or worsen dry skin. In this column, we’ll look at three common medications that may contribute to hair loss or thinning by ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

It’s true to say that drug usage has a variety of negative consequences for its users and, on the whole, governments are right to advise against it. People in New York who smoke cannabis should ...

Isotretinoin, commonly called Accutane, is the only approved treatment for severe acne. Although isotretinoin is extremely effective in most individuals with acne, some experience recurrence.

Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of ...

Blockbuster obesity drugs such as Ozempic have been celebrated for their ability to promote weight loss and treat a surprising range of other conditions, from heart problems to Parkinson’s disease.

Isotretinoin, commonly referred to as Accutane, is the only approved medical treatment capable of inducing long-term remission of severe acne. Although highly effective, some individuals ...

Updated drug information handout outdoes FDA's version in clinical trial Feb 6, 2025 Chronic inflammation's connection to atrial fibrillation points to IL-1β as a promising treatment target ...